Homocysteine's role in Age-Related Macular Degeneration
同型半胱氨酸在年龄相关性黄斑变性中的作用
基本信息
- 批准号:10558578
- 负责人:
- 金额:$ 36.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Age related macular degenerationAgingAmino AcidsBiological AssayBlindnessBloodCellsChoroidal NeovascularizationCystathionine beta-SynthaseDataDevelopmentDietary SupplementationElderlyEndothelial CellsEndotheliumEnzymesEvaluationExhibitsExperimental ModelsFluorescein AngiographyFolic AcidFunctional disorderGeneticGlycolysisGlycolysis InductionGoalsHomocysteineHumanHyperhomocysteinemiaIn VitroIntestinal AbsorptionJointsKnockout MiceLasersLife ExpectancyMediatingMedicalMetabolicMetabolismMethylationMitochondriaModalityModelingModificationMolecularMusN-Methyl-D-Aspartate ReceptorsN-MethylaspartateOptical Coherence TomographyOxidative PhosphorylationPathogenesisPathway interactionsPatientsPhenotypePhotoreceptorsPopulationPrevalenceProteinsReportingRespirationRetinaRiskRoleSLC2A1 geneSerumSignal PathwaySignal TransductionStructure of retinal pigment epitheliumTestingTherapeuticTight JunctionsUp-RegulationVascular Endothelial Growth FactorsVision DisordersVitamin B 12Vitamin B6Wild Type Mousebevacizumabconditional knockoutelectric impedanceexperimental studyfluorescein isothiocyanate dextranfolic acid supplementationgene therapygenetic manipulationin vivoinhibitorintravitreal injectionmouse modeloverexpressionpharmacologicpreservationpreventreceptorretinal damagetherapeutic target
项目摘要
Summary/Abstract
Age-related macular degeneration (AMD) is the leading cause of vision loss in among elderly populations.
Elevated homocysteine (Hcy), also known as hyperhomocysteinemia (HHcy) has been reported in patients with
AMD; thereby suggesting an association between HHcy and the risk of AMD. Recently, we reported retinal
changes similar to AMD in a mouse model of HHcy which lacks Cystathionine-β-synthase (cbs+/-) or received
intravitreal injections of Hcy. These models showed significant retinal pigment epithelium (RPE) dysfunction and
choroidal neovascularization (CNV) However, the lack of understanding the molecular/cellular mechanisms of
these changes is a critical barrier in proposing Hcy as a therapeutic target in AMD. Our preliminary data show
that HHcy-induced RPE dysfunction is associated with the upregulation of the N-methyl-D-aspartate (NMDAr)
and GLUT1 receptors and increased glycolysis. Hence, we hypothesize that HHcy contributes to the
pathogenesis of AMD via activation of the NMDAr and GLUT1 signaling pathways that induce the metabolic
switch from oxidative phosphorylation to glycolysis. Therefore, elimination of excess Hcy through
pharmacological or genetic intervention could be beneficial in the treatment of AMD. To test our hypothesis, we
will conduct in vitro experiments, using RPE and choroidal endothelial cells (CEC) and in vivo using cbs+/-, wild
type mice receiving intravitreal injection of Hcy and mice lacking the endothelial or RPE NMDAr (NMDAr-/-E or
NMDAr-/-R respectively). Our specific aims include: 1: Testing the hypothesis that HHcy induces the
metabolic switch from mitochondrial respiration to glycolysis via activation of GLUT1 in RPE cells: We
will examine the changes in the retinal expression and localization of GLUT1, mitochondrial respiration,
glycolysis and rate-limiting glycolytic enzymes in HHcy models. Moreover, we will determine the effect of GLUT1
inhibition on HHcy-induced RPE dysfunction and CNV. Aim 2: Testing the hypothesis that inhibition of
NMDAr preserves RPE function and reduces the development of CNV under HHcy. We will examine the
effects of pharmacological inhibition or genetic manipulation of the NMDAr on HHcy-induced RPE dysfunction
and CNV. The effect of intravitreal injection of Hcy will be evaluated in NMDAr-/-E or NMDAr-/-R as compared to
wild type and cbs+/- mice with or without NAMDAr inhibitors. Parallel in vitro experiments will be performed on
RPE and CEC subjected to Hcy with or without NMDAr inhibitors followed by assessment of RPE function and
angiogenic potential of CEC. Aim 3: Testing the hypothesis that elimination of excess Hcy by dietary
supplementation or genetic/ pharmacological modifications prevents the progression of AMD. Hcy
clearance will be enhanced in models of HHcy through two approaches, followed by assessment of RPE function
and angiogenic potential of CEC: (a) Enhancing the remethylation pathway of Hcy metabolism using vitamins
B6, B12 and folic acid supplementation. (b) Enhancing the transsulforation pathway of Hcy metabolism via CBS
overexpression. Successful clearance of excess Hcy holds immense promise in the treatment of AMD.
摘要/文摘
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration.
基因表达、剪接和等位基因特异性表达的模式因黄斑组织和年龄相关性黄斑变性的临床阶段而异。
- DOI:10.3390/cells12232668
- 发表时间:2023-11-21
- 期刊:
- 影响因子:6
- 作者:Shwani, Treefa;Zhang, Charles;Owen, Leah A.;Shakoor, Akbar;Vitale, Albert T.;Lillvis, John H.;Barr, Julie L.;Cromwell, Parker;Finley, Robert;Husami, Nadine;Au, Elizabeth;Zavala, Rylee A.;Graves, Elijah C.;Zhang, Sarah X.;Farkas, Michael H.;Ammar, David A.;Allison, Karen M.;Tawfik, Amany;Sherva, Richard M.;Li, Mingyao;Stambolian, Dwight;Kim, Ivana K.;Farrer, Lindsay A.;DeAngelis, Margaret M.
- 通讯作者:DeAngelis, Margaret M.
Isolation of Primary Mouse Retinal Pigmented Epithelium Cells.
- DOI:10.3791/63543
- 发表时间:2022-11-04
- 期刊:
- 影响因子:0
- 作者:Tomaszewski R;Rajpurohit P;Cheng M;Tawfik A
- 通讯作者:Tawfik A
Warburg Effect as a Novel Mechanism for Homocysteine-Induced Features of Age-Related Macular Degeneration.
- DOI:10.3390/ijms24021071
- 发表时间:2023-01-05
- 期刊:
- 影响因子:5.6
- 作者:Samra, Yara A.;Zaidi, Yusra;Rajpurohit, Pragya;Raghavan, Raju;Cai, Lun;Kaddour-Djebbar, Ismail;Tawfik, Amany
- 通讯作者:Tawfik, Amany
A novel interaction between soluble epoxide hydrolase and the AT1 receptor in retinal microvascular damage.
- DOI:10.1016/j.prostaglandins.2020.106449
- 发表时间:2020-06
- 期刊:
- 影响因子:2.9
- 作者:Wang MH;Ibrahim AS;Hsiao G;Tawfik A;Al-Shabrawey M
- 通讯作者:Al-Shabrawey M
Role of Endothelial ADAM17 in Early Vascular Changes Associated with Diabetic Retinopathy.
内皮 ADAM17 在与糖尿病视网膜病变相关的早期血管变化中的作用。
- DOI:10.3390/jcm9020400
- 发表时间:2020
- 期刊:
- 影响因子:3.9
- 作者:Shalaby,Lamiaa;Thounaojam,Menaka;Tawfik,Amany;Li,Junnan;Hussein,Khaled;Jahng,WanJin;Al-Shabrawey,Mohamed;Kwok,HangFai;Bartoli,Manuela;Gutsaeva,Diana
- 通讯作者:Gutsaeva,Diana
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amany M Tawfik其他文献
Amany M Tawfik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amany M Tawfik', 18)}}的其他基金
Homocysteine's role in Age-Related Macular Degeneration
同型半胱氨酸在年龄相关性黄斑变性中的作用
- 批准号:
10457086 - 财政年份:2021
- 资助金额:
$ 36.24万 - 项目类别:
Homocysteine's role in Age-Related Macular Degeneration
同型半胱氨酸在年龄相关性黄斑变性中的作用
- 批准号:
10329922 - 财政年份:2021
- 资助金额:
$ 36.24万 - 项目类别:
Homocysteine's role in Age-Related Macular Degeneration
同型半胱氨酸在年龄相关性黄斑变性中的作用
- 批准号:
10090473 - 财政年份:2019
- 资助金额:
$ 36.24万 - 项目类别:
相似海外基金
Maintenance of undifferentiated state of mesenchymal stem cells using amino acids for the regulation of stem cell aging
使用氨基酸维持间充质干细胞的未分化状态以调节干细胞衰老
- 批准号:
15K15708 - 财政年份:2015
- 资助金额:
$ 36.24万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Elucidation of the expression of D-amino acids induced by cellular damage with aging or chronic inflammations
阐明衰老或慢性炎症引起的细胞损伤诱导的 D-氨基酸表达
- 批准号:
24791743 - 财政年份:2012
- 资助金额:
$ 36.24万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Dietary supplements and aging muscle: specific amino acids to combat sarcopenia
膳食补充剂和衰老肌肉:对抗肌肉减少症的特定氨基酸
- 批准号:
7935268 - 财政年份:2010
- 资助金额:
$ 36.24万 - 项目类别:
Dietary supplements and aging muscle: specific amino acids to combat sarcopenia
膳食补充剂和衰老肌肉:对抗肌肉减少症的特定氨基酸
- 批准号:
7749120 - 财政年份:2010
- 资助金额:
$ 36.24万 - 项目类别:
MICRORNA EXPRESSION IN AGING: EFFECTS OF EXERCISE AND ESSENTIAL AMINO ACIDS
衰老过程中的微生物表达:运动和必需氨基酸的影响
- 批准号:
7952174 - 财政年份:2009
- 资助金额:
$ 36.24万 - 项目类别:
ESSENTIAL AMINO ACIDS AND RESISTANCE EXERCISE IN AGING
必需氨基酸和抗衰老运动
- 批准号:
7719195 - 财政年份:2008
- 资助金额:
$ 36.24万 - 项目类别:
ESSENTIAL AMINO ACIDS AND RESISTANCE EXERCISE IN AGING
必需氨基酸和抗衰老运动
- 批准号:
7605426 - 财政年份:2007
- 资助金额:
$ 36.24万 - 项目类别:














{{item.name}}会员




